GFM Network News


Bayer takes major writedown, flags Roundup settlement bill

Company writes down agribusiness assets

Frankfurt | Reuters — Bayer is facing a double hit from a higher legal bill for claims relating to weedkiller Roundup as well as 9.25 billion euros (C$14.2 billion) in impairments on agriculture businesses, much of it related to its Monsanto deal. The company said the write-downs, driven by weaker demand from farmers due to […] Read more



Bayer plans more cost cuts, impairment charges

Pandemic now expected to hit crop science wing

Berlin | Reuters — German drugs and chemical company Bayer announced plans on Wednesday for more than 1.5 billion euros (C$2.34 billion) of cost cuts as of 2024 and said it would take impairment charges on its agricultural business as it battles with low commodity prices. Bayer said that the impact of the coronavirus on […] Read more

Bayer loses California appeal of Roundup verdict

Damages payable to plaintiff are further reduced

Reuters — Bayer AG failed to persuade a California appeals court to overturn a verdict favouring a school groundskeeper who claimed its Roundup weed killer caused his cancer but reduced the amount of damages by 74 per cent, to US$20.5 million. The decision by the California Court of Appeal came after a San Francisco jury […] Read more


Bayer puts Roundup future claims settlement on hold

Judge questions proposal for third-party scientists to rule on chemical's carcinogenicity

Frankfurt | Reuters — Bayer was forced on Wednesday to delay part of a proposed settlement of allegations that its widely used herbicide Roundup caused cancer after a U.S. judge questioned its plan to deal with future claims. The German company said that lawyers representing those preparing a class action had withdrawn a request for […] Read more

Investors pile into Bayer bond to pay settlement charges

Amsterdam | Reuters — Investors piled into a Bayer bond on Wednesday that will help pay for a long-negotiated settlement of U.S. lawsuits claiming its widely-used herbicide Roundup caused cancer. Demand for the four-tranche bond sale, whose proceeds will include the litigation payments, exceeded 17.5 billion euros, nearly three times the six billion euros (C$9.15 […] Read more


U.S. settlements not expected to change availability, labels for glyphosate, dicamba

Bayer to pay up to US$12 billion to resolve ag chem, PCB claims; company is "not contemplating" a Canadian glyphosate settlement

Updated, June 25 — Farmers in Canada, the U.S. and elsewhere shouldn’t expect any changes to availability or label directions for Bayer’s stable of glyphosate and dicamba herbicides, coming out of a massive settlement for thousands of lawsuits, the company says. The German company announced Wednesday it expects to spend up to $12 billion in […] Read more

Bayer reportedly near glyphosate settlement after lengthy talks

Proposed settlement said to include $2 billion for future cases

Reuters — Germany’s Bayer is set to reach a settlement this week with U.S. plaintiffs that claim its glyphosate-based herbicides cause cancer, two people familiar with the matter told Reuters. After more than a year of talks, however, some details and the overall amount of the settlement have yet to be finalised, one of the […] Read more


U.S. court blocks California cancer label on Roundup

WHO agency's ruling alone insufficient, judge says

Reuters — A U.S. federal appeals court on Monday blocked California from requiring that Bayer label its glyphosate-based herbicide Roundup with a cancer warning, handing the company a victory in its ongoing litigation over the product. In his ruling, U.S. District Judge William Shubb called California’s cancer warning misleading and said the state’s label is […] Read more

Proxy advisers split over endorsing Bayer management

Chemical giant to host AGM April 28

Frankfurt | Reuters — Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer, according to recommendations submitted by proxy voting firms. Bayer is due to host its annual general meeting on April 28 but the company still faces potentially huge litigation risks stemming from […] Read more